Puricase serves a clear need in treatment-failure gout. The product treats a highly symptomatic disease whose sufferers are traditionally affluent and have healthcare willing to accept higher than Wall Street estimate prices for drugs treating… More
A very curious development today in Savient, which requires familiarity with FDA approval procedures as well as the history of this particularly interesting baby biotech to understand. I was at one point very confused about the approval process after… More